1,602
Views
47
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The COPD Biomarker Qualification Consortium (CBQC)

, , , , , , , , , , , , , , , , & show all
Pages 367-377 | Published online: 28 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Eda Celikbas, Deborah Penque & Jerome Zoidakis. (2019) Systematic review on recent potential biomarkers of chronic obstructive pulmonary disease. Expert Review of Molecular Diagnostics 19:1, pages 37-45.
Read now
Eva Grolimund, Alexander Kutz, Robert J. Marlowe, Alaadin Vögeli, Murat Alan, Mirjam Christ-Crain, Robert Thomann, Claudine Falconnier, Claus Hoess, Christoph Henzen, Werner Zimmerli, Beat Mueller & Philipp Schuetz. (2015) Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type. COPD: Journal of Chronic Obstructive Pulmonary Disease 12:3, pages 300-310.
Read now
Chitra Lal & Charlie Strange. (2015) Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 16:3, pages 427-434.
Read now
Divya Mohan, Nichola S. Gale, Carmel M. McEniery, Charlotte E. Bolton, John R. Cockcroft, William MacNee, Jonathan Fuld, David A. Lomas, Peter M. A. Calverley, Dennis J. Shale, Bruce E. Miller, Ian B. Wilkinson, Ruth Tal-Singer & Michael I. Polkey. (2014) Evaluating the Role of Inflammation in Chronic Airways Disease: The ERICA Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 11:5, pages 552-559.
Read now

Articles from other publishers (43)

Kartik Munta & SunilKumar Nadikuda. 2023. Biomarkers in Trauma, Injury and Critical Care. Biomarkers in Trauma, Injury and Critical Care 597 609 .
Pelin Uysal. 2022. Biomarkers in Medicine. Biomarkers in Medicine 425 439 .
Mark W Orme, Ilaria Pina & Sally J Singh. (2022) The untapped potential of physical activity monitoring for quality assurance of field-based walking tests in clinical respiratory trials. Chronic Respiratory Disease 19, pages 147997312210893.
Crossref
Kartik Munta & SunilKumar Nadikuda. 2022. Biomarkers in Trauma, Injury and Critical Care. Biomarkers in Trauma, Injury and Critical Care 1 13 .
Chris Burtin, Divya Mohan, Thierry Troosters, Henrik Watz, Nicholas S. Hopkinson, Judith Garcia-Aymerich, Marilyn L. Moy, Ioannis Vogiatzis, Harry B. Rossiter, Sally Singh, Debora D. Merrill, Alan Hamilton, Stephen I. Rennard, Malin Fageras, Stefano Petruzzelli, Ruth Tal-Singer, Erin Tomaszewski, Solange Corriol-Rohou, Carolyn L. Rochester, Frank C. Sciurba, Richard Casaburi, William D.-C. Man, Rob C. Van Lummel, Christopher B. Cooper, Heleen Demeyer, Martijn A. Spruit & Anouk Vaes. (2021) Objectively Measured Physical Activity as a COPD Clinical Trial Outcome. Chest 160:6, pages 2080-2100.
Crossref
Byron M. Thomashow, David M. Mannino, Ruth Tal-Singer & James D. Crapo. (2021) A rapidly changing understanding of COPD: World COPD Day from the COPD Foundation. American Journal of Physiology-Lung Cellular and Molecular Physiology 321:5, pages L983-L987.
Crossref
Taro Koba, Yoshito Takeda, Ryohei Narumi, Takashi Shiromizu, Yosui Nojima, Mari Ito, Muneyoshi Kuroyama, Yu Futami, Takayuki Takimoto, Takanori Matsuki, Ryuya Edahiro, Satoshi Nojima, Yoshitomo Hayama, Kiyoharu Fukushima, Haruhiko Hirata, Shohei Koyama, Kota Iwahori, Izumi Nagatomo, Mayumi Suzuki, Yuya Shirai, Teruaki Murakami, Kaori Nakanishi, Takeshi Nakatani, Yasuhiko Suga, Kotaro Miyake, Takayuki Shiroyama, Hiroshi Kida, Takako Sasaki, Koji Ueda, Kenji Mizuguchi, Jun Adachi, Takeshi Tomonaga & Atsushi Kumanogoh. (2021) Proteomics of serum extracellular vesicles identifies a novel COPD biomarker, fibulin-3 from elastic fibres. ERJ Open Research 7:1, pages 00658-2020.
Crossref
Lauge SørensenMads NielsenJens PetersenJesper H. PedersenAsger DirksenMarleen de Bruijne. (2020) Chronic Obstructive Pulmonary Disease Quantification Using CT Texture Analysis and Densitometry: Results From the Danish Lung Cancer Screening Trial. American Journal of Roentgenology 214:6, pages 1269-1279.
Crossref
Tao Dong, Simão Santos, Zhaochu Yang, Shuai Yang & Niels E. Kirkhus. (2020) Sputum and salivary protein biomarkers and point-of-care biosensors for the management of COPD. The Analyst 145:5, pages 1583-1604.
Crossref
V.S. Priyadharshini & Luis M. Teran. 2020. Precision Medicine for Investigators, Practitioners and Providers. Precision Medicine for Investigators, Practitioners and Providers 255 261 .
Ashraf Fawzy, Julie A. Anderson, Nicholas J. Cowans, Courtney Crim, Robert Wise, Julie C. Yates & Nadia N. Hansel. (2019) Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPD. Respiratory Research 20:1.
Crossref
Xuan Chen, Tao Dong, Xueyong Wei, Zhaochu Yang, Nuno Miguel Matos Pires, Juan Ren & Zhuangde Jiang. (2019) Electrochemical methods for detection of biomarkers of Chronic Obstructive Pulmonary Disease in serum and saliva. Biosensors and Bioelectronics 142, pages 111453.
Crossref
Elizabeth A. Regan, Craig P. Hersh, Peter J. Castaldi, Dawn L. DeMeo, Edwin K. Silverman, James D. Crapo & Russell P. Bowler. (2019) Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene. American Journal of Respiratory Cell and Molecular Biology 61:2, pages 143-149.
Crossref
Ianthe Piscaer, Jody M. W. van den Ouweland, Kristina Vermeersch, Niki L. Reynaert, Frits M. E. Franssen, Spencer Keene, Emiel F. M. Wouters, Wim Janssens, Cees Vermeer & Rob Janssen. (2019) Low Vitamin K Status Is Associated with Increased Elastin Degradation in Chronic Obstructive Pulmonary Disease. Journal of Clinical Medicine 8:8, pages 1116.
Crossref
Tamara Pavić, Dario Dilber, Domagoj Kifer, Najda Selak, Toma Keser, Đivo Ljubičić, Andrea Vukić Dugac, Gordan Lauc, Lada Rumora & Olga Gornik. (2018) N-glycosylation patterns of plasma proteins and immunoglobulin G in chronic obstructive pulmonary disease. Journal of Translational Medicine 16:1.
Crossref
Rob Janssen, Bart de Brouwer, Jan H. von der Thüsen & Emiel F.M. Wouters. (2018) Copper as the most likely pathogenic divergence factor between lung fibrosis and emphysema. Medical Hypotheses 120, pages 49-54.
Crossref
Sally J. Singh & Theresa C. Harvey-Dunstan. 2018. Clinical Exercise Testing. Clinical Exercise Testing 175 195 .
Jeong H. Yun, Andrew Lamb, Robert Chase, Dave Singh, Margaret M. Parker, Aabida Saferali, Jørgen Vestbo, Ruth Tal-Singer, Peter J. Castaldi, Edwin K. Silverman, Craig P. Hersh, James D. Crapo, Edwin K. Silverman, Barry J. Make, Elizabeth A. Regan, Terri Beaty, Ferdouse Begum, Robert Busch, Peter J. Castaldi, Michael Cho, Dawn L. DeMeo, Adel R. Boueiz, Marilyn G. Foreman, Eitan Halper-Stromberg, Nadia N. Hansel, Megan E. Hardin, Lystra P. Hayden, Craig P. Hersh, Jacqueline Hetmanski, Brian D. Hobbs, John E. Hokanson, Nan Laird, Christoph Lange, Sharon M. Lutz, Merry-Lynn McDonald, Margaret M. Parker, Dandi Qiao, Elizabeth A. Regan, Stephanie Santorico, Edwin K. Silverman, Emily S. Wan, Sungho Won, Mustafa Al Qaisi, Harvey O. Coxson, Teresa Gray, MeiLan K. Han, Eric A. Hoffman, Stephen Humphries, Francine L. Jacobson, Philip F. Judy, Ella A. Kazerooni, Alex Kluiber, David A. Lynch, John D. NewellJr.Jr., Elizabeth A. Regan, James C. Ross, Raul San Jose Estepar, Joyce Schroeder, Jered Sieren, Douglas Stinson, Berend C. Stoel, Juerg Tschirren, Edwin Van Beek, Bram van Ginneken, Eva van Rikxoort, George Washko, Carla G. Wilson, Robert Jensen, Douglas Everett, Jim Crooks, Camille Moore, Matt Strand, Carla G. Wilson, John E. Hokanson, John Hughes, Gregory Kinney, Sharon M. Lutz, Katherine Pratte, Kendra A. Young, Jeffrey L. Curtis, Carlos H. Martinez, Perry G. Pernicano, Nicola Hanania, Philip Alapat, Mustafa Atik, Venkata Bandi, Aladin Boriek, Kalpatha Guntupalli, Elizabeth Guy, Arun Nachiappan, Amit Parulekar, Dawn L. DeMeo, Craig Hersh, Francine L. Jacobson, George Washko, R. Graham Barr, John Austin, Belinda D'Souza, Gregory D.N. Pearson, Anna Rozenshtein, Byron Thomashow, Neil MacIntyreJr.Jr., H. Page McAdams, Lacey Washington, Charlene McEvoy, Joseph Tashjian, Robert Wise, Robert Brown, Nadia N. Hansel, Karen Horton, Allison Lambert, Nirupama Putcha, Richard Casaburi, Alessandra Adami, Matthew Budoff, Hans Fischer, Janos Porszasz, Harry Rossiter, William Stringer, Amir Sharafkhaneh, Charlie Lan, Christine Wendt, Brian Bell, Marilyn G. Foreman, Eugene Berkowitz, Gloria Westney, Russell Bowler, David A. Lynch, Richard Rosiello, David Pace, Gerard Criner, David Ciccolella, Francis Cordova, Chandra Dass, Gilbert D'Alonzo, Parag Desai, Michael Jacobs, Steven Kelsen, Victor Kim, A. James Mamary, Nathaniel Marchetti, Aditi Satti, Kartik Shenoy, Robert M. Steiner, Alex Swift, Irene Swift, Maria Elena Vega-Sanchez, Mark Dransfield, William Bailey, Surya Bhatt, Anand Iyer, Hrudaya Nath, J. Michael Wells, Joe Ramsdell, Paul Friedman, Xavier Soler, Andrew Yen, Alejandro P. Comellas, John NewellJr.Jr., Brad Thompson, MeiLan K. Han, Ella Kazerooni, Carlos H. Martinez, Joanne Billings, Abbie Begnaud, Tadashi Allen, Frank Sciurba, Jessica Bon, Divay Chandra, Carl Fuhrman, Joel Weissfeld, Antonio Anzueto, Sandra Adams, Diego Maselli-Caceres, Mario E. Ruiz, Y. Ivanov, K. Kostov, J. Bourbeau, M. Fitzgerald, P. Hernandez, K. Killian, R. Levy, F. Maltais, D. O'Donnell, J. Krepelka, J. Vestbo, E. Wouters, D. Quinn, P. Bakke, M. Kosnik, A. Agusti, J. Sauleda, P. de Mallorca, Y. Feschenko, V. Gavrisyuk, L. Yashina Kiev, N. Monogarova, P. Calverley, D. Lomas, W. MacNee, D. Singh, J. Wedzicha, A. Anzueto, S. Braman, R. Casaburi, B. Celli, G. Giessel, M. Gotfried, G. Greenwald, N. Hanania, D. Mahler, B. Make, S. Rennard, C. Rochester, P. Scanlon, D. Schuller, F. Sciurba, A. Sharafkhaneh, T. Siler, E. Silverman, A. Wanner, R. Wise, R. ZuWallack, H. Coxson, C. Crim, L. Edwards, D. Lomas, W. MacNee, E. Silverman, R. Tal Singer, J. Vestbo, J. Yates, A. Agusti, P. Calverley, B. Celli, C. Crim, B. Miller, W. MacNee, S. Rennard, R. Tal-Singer, E. Wouters & J. Yates. (2018) Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. Journal of Allergy and Clinical Immunology 141:6, pages 2037-2047.e10.
Crossref
George R. Washko. (2018) Susceptibility to Inhalational Lung Injury: We Need More Than the FEV 1 . Annals of the American Thoracic Society 15:2, pages 156-157.
Crossref
Ianthe Piscaer, Emiel F. M. Wouters, Cees Vermeer, Wim Janssens, Frits M. E. Franssen & Rob Janssen. (2017) Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?. Respiratory Research 18:1.
Crossref
Alaadin Vögeli, Manuel Ottiger, Marc A. Meier, Christian Steuer, Luca Bernasconi, Andreas Huber, Mirjam Christ-Crain, Christoph Henzen, Claus Hoess, Robert Thomann, Werner Zimmerli, Beat Mueller & Philipp Schuetz. (2017) Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung 195:6, pages 717-727.
Crossref
Stephen I. Rennard, Debora Merrill, Ruth Tal-Singer & Frank C. Sciurba. (2017) The St. George’s Respiratory Questionnaire Appendix to the Food and Drug Administration Draft Guidance on COPD. Chest 152:5, pages 914-916.
Crossref
Ray Bakhtiar. 2017. Targeted Biomarker Quantitation by LC–MS. Targeted Biomarker Quantitation by LC–MS 17 33 .
NALAN OGAN, sezen baglan UZUNGET & Berkay EKİCİ. (2017) Kronik Obstrüktif Akciğer Hastalığının Akut Alevlenmesi ile Nötrofil-Lenfosit Oranı ve Serum Ürik Asit Düzeyleri Arasındaki İlişki. TURKISH JOURNAL of CLINICS and LABORATORY.
Crossref
Bartolome Celli, Kay Tetzlaff, Gerard Criner, Michael I. Polkey, Frank Sciurba, Richard Casaburi, Ruth Tal-Singer, Ariane Kawata, Debora Merrill & Stephen Rennard. (2016) The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium. American Journal of Respiratory and Critical Care Medicine 194:12, pages 1483-1493.
Crossref
Bruce E. Miller, Ruth Tal-Singer, Stephen I. Rennard, Armin Furtwaengler, Nancy Leidy, Michael Lowings, Ubaldo J. Martin, Thomas R. Martin, Debora D. Merrill, Jeffrey Snyder, John Walsh & David M. Mannino. (2016) Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. American Journal of Respiratory and Critical Care Medicine 193:6, pages 607-613.
Crossref
Alvar Agusti, Joaquim Gea & Rosa Faner. (2016) Biomarkers, the control panel and personalized COPD medicine. Respirology 21:1, pages 24-33.
Crossref
Mona Lärstad, Ann-Charlotte Almstrand, Per Larsson, Björn Bake, Sven Larsson, Evert Ljungström, Ekaterina Mirgorodskaya & Anna-Carin Olin. (2015) Surfactant Protein A in Exhaled Endogenous Particles Is Decreased in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Pilot Study. PLOS ONE 10:12, pages e0144463.
Crossref
Truls S Ingebrigtsen, Jacob L Marott, Line Rode, Jørgen Vestbo, Peter Lange & Børge G Nordestgaard. (2015) Fibrinogen and α 1 -antitrypsin in COPD exacerbations . Thorax 70:11, pages 1014-1021.
Crossref
Puja Kohli, Victor Pinto-Plata, Miguel Divo, Atul Malhotra, R. Scott Harris, Aili Lazaar, Aiden Flynn, Ruth Tal-Singer, Reynold A. Panettieri & Bartolome Celli. (2015) Functional Capacity, Health Status, and Inflammatory Biomarker Profile in a Cohort of Patients With Chronic Obstructive Pulmonary Disease. Journal of Cardiopulmonary Rehabilitation and Prevention 35:5, pages 348-355.
Crossref
Claire Rooney & Tariq Sethi. (2015) Biomarkers for precision medicine in airways disease. Annals of the New York Academy of Sciences 1346:1, pages 18-32.
Crossref
Hana Müllerova, Diego J. Maselli, Nicholas Locantore, Jørgen Vestbo, John R. Hurst, Jadwiga A. Wedzicha, Per Bakke, Alvar Agusti & Antonio Anzueto. (2015) Hospitalized Exacerbations of COPD. Chest 147:4, pages 999-1007.
Crossref
David M. Mannino. (2015) Biomarkers in COPD: the search continues!. European Respiratory Journal 45:4, pages 872-874.
Crossref
Daniel M. Rose, Richard Marshall & Mark W. Surber. (2015) Pharmaceutical industry, academia and patient advocacy organizations: What is the recipe for synergic (win-win-win) collaborations?. Respirology 20:2, pages 185-191.
Crossref
Philipp Schuetz, Robert J. Marlowe & Beat Mueller. (2015) The prognostic blood biomarker proadrenomedullin for outcome prediction in patients with chronic obstructive pulmonary disease (COPD): a qualitative clinical review. Clinical Chemistry and Laboratory Medicine (CCLM) 53:4.
Crossref
Katherine J. Baines, Thomas K. Wright, Jodie L. Simpson, Vanessa M. McDonald, Lisa G. Wood, Kristy S. Parsons, Peter A. Wark & Peter G. Gibson. (2015) Airway β -Defensin-1 Protein Is Elevated in COPD and Severe Asthma . Mediators of Inflammation 2015, pages 1-8.
Crossref
Sofie Lock-Johansson, Jørgen Vestbo & Grith Lykke Sorensen. (2014) Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease. Respiratory Research 15:1.
Crossref
Eric S. White, Kevin K. Brown, Harold R. Collard, Craig S. Conoscenti, Gregory P. Cosgrove, Kevin R. Flaherty, Jonathan A. Leff, Fernando J. Martinez, Jesse Roman, Dan Rose, Shelia Violette & Naftali Kaminski. (2014) Open-Access Biorepository for Idiopathic Pulmonary Fibrosis. The Way Forward. Annals of the American Thoracic Society 11:8, pages 1171-1175.
Crossref
Rosa Faner, Ruth Tal-Singer, John H Riley, Bartolomé Celli, Jørgen Vestbo, William MacNee, Per Bakke, Peter M A Calverley, Harvey Coxson, Courtney Crim, Lisa D Edwards, Nick Locantore, David A Lomas, Bruce E Miller, Stephen I Rennard, Emiel F M Wouters, Julie C Yates, Edwin K Silverman & Alvar Agusti. (2014) Lessons from ECLIPSE: a review of COPD biomarkers. Thorax 69:7, pages 666-672.
Crossref
Jørgen Vestbo, Alvar Agusti, Emiel F. M. Wouters, Per Bakke, Peter M. A. Calverley, Bartolome Celli, Harvey Coxson, Courtney Crim, Lisa D. Edwards, Nicholas Locantore, David A. Lomas, William MacNee, Bruce Miller, Stephen I. Rennard, Edwin K. Silverman, Julie C. Yates & Ruth Tal-Singer. (2014) Should We View Chronic Obstructive Pulmonary Disease Differently after ECLIPSE?. A Clinical Perspective from the Study Team. American Journal of Respiratory and Critical Care Medicine 189:9, pages 1022-1030.
Crossref
M. Fisk, D. Mohan, J. Cheriyan, L. Yang, J. Fuld, C.M. McEniery, R. Tal-Singer, M.I. Polkey & I.B. Wilkinson. (2014) Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): Rationale and protocol. Artery Research 8:1, pages 24-34.
Crossref
Henrik Watz, Helen Barnacle, Benjamin F Hartley & Robert Chan. (2014) Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial. The Lancet Respiratory Medicine 2:1, pages 63-72.
Crossref
Judith A Brebner. (2013) Early chronic obstructive pulmonary disease : Beyond spirometry. World Journal of Respirology 3:3, pages 57.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.